______________________________________________________________________Revista Cientifica, FCV-LUZ / Vol. XXXIII, rcfcv-e33244, 1 – 8
7 of 8
As mentioned above, with the results of the statistical analysis it
was found a moderate agreement regarding the concordance between
clinical and histopathological staging. Cohen's weighted Kappa index,
with a 95% condence interval, was k = 0.48 [0.16 – 0.81]. These data
are consistent with histopathological results, since it was found both
malignant T1 (1 to 3 cm) tumors and benign T2 (3 to 5 cm) tumors.
CONCLUSIONS
In the present work, the concordance between clinical aspect of the
tumor and histopathology was low, since malignant tumors of small size
(classied as T1: 1 to 3 cm) and benign tumors of low size (classied as
T2: 3 to 5 cm) were found. It seems that clinically there is a tendency to
classify tumors towards greater severity. Studies with a larger population
size are required to obtain more consistent conclusions.
BIBLIOGRAPHIC REFERENCES
[1] Sorenmo K, Shofer F, Goldschmidt M. Effect of spaying and
timing of spaying on survival of dogs with mammary carcinoma.
J. Vet. Int. Med. 2000; 14:266–270.
[2] Hermo G, García M, Torres P, Gobello C. Tumores de mama en
la perra. Cien. Vet. 2005; 7(1):1–25.
[3] Ochiat K, Ishiguro–Oonuma T, Yoshikawa Y, Udagawa C,
Kato Y, Watanabe M, Bonkobara M, Morimatsu M, Toshinori.
B. Polymorphisms of canine BRCA2 BRC repeats affecting
interaction with RAD51. Biomed. Res. (Tokyo) 2015; 36 (2):155–158.
[4] Al–Dissi A, Haines D, Singh B, Kidney B. Immunohistochemical
expression of vascular endothelial growth factor and vascular
endothelial growth factor receptor–2 in canine simple mammary
gland adenocarcinomas. Canad. Vet. J. 2010; 51:1109–1114.
[5] Paoloni M, Khanna C. Comparative Oncology Today. Vet. Clin.
North America: Small Anim. Pract. 2007; 37(6):1023–32.
[6] Sobral R, Honda S, Katayama M, Brentani H, Brentani M, Patrão
D, Folgueira M. Tumor slices as a model to evaluate doxorubicin
in vitro treatment and expression of trios of genes PRSSI I, MTSS
I, CLPTM I and PRSSI I, MTSS I, SMYD2 in canine mammary gland
cancer. Acta Vet. Scandinavica. 2008; 50:27.
[7] Liu D, Xiong H, Ellis A, Northrup N, Rodriguez C, O'Regan R,
Dalton S, Zhao S. Molecular homology and difference between
spontaneous canine mammary cancer and human breast cancer.
Cancer Res. 2014; 74 (18):5045–56.
[8] Ruthanne C, Garret L. Tumores genitourinarios y de glándula
mamaria. En: Ettinger, S, Feldman, E (eds.). Tratado de Medicina
Interna Veterinaria, enfermedades del perro y el gato. 6ta. Ed.
Volumen 1. Madrid. Ed. Elsevier. 2007; p 784 –789.
[9] Lana, S. Tumores de glándula mamaria. En: Withrow, S.,
Macewen, S.(eds.) Oncología clínica de pequeños animales, 4ª.
ed. Multimedica. 2008; p. 605– 620.
[10] Rivera P, Melin M, Biagi T, Fall T, Häggström J, Lindblad–Toh K,
von Euler H. Mammary Tumor Development in Dogs Is Associated
with BRCA1 and BRCA2. Cancer Res. 2009; 69:8770–8774.
[11] Ogilvie G, Moore A. Neoplasia mamaria. En: Ogilvie GK., Moore
A.S. (eds.). Manejo del paciente canino oncológico. United
States, Intermédica. 2008; p 675 – 687.
[12] Owen L. A comparative study of canine and human breasy cancer.
Invest. Cell Pathol. 1979; 2:257 – 275.
[13] Cassali G, Bertagnolli A, Lavalle G, Tavares W, Ferreira E, Campos C.
Perspectives for diagnosis, prognosis and treatment of mammary
neoplasias in dogs. 34th World Small Animal Veterinary Congress
– WSAVA. 07/21–24, São Paulo. 2009; p 680–682.
[14] Vail D, Thamm D, Liptak J. Withrow & MacEwen’s Small Animal
Clinical Oncology, 6a. ed., cap.28 Tumors of the mammary gland.
Ed. Elsevier. 2020; p 604–625.
[15] Misdorp W, Else R, Hellmen E, Lipscomb T. Histological
classication of mammary tumours of the dog and the cat.
International Histological Classication of Tumours of Domestic
Animals, 2
nd
. Series. Bulletin of the World Health Organization/
American Registry of Pathology. 1999; p 18–25.
[16] Goldschmidt M, Peña L, Rasotto R, Zapulli V. Classication and
grading of canine mammary tumors. Vet. Pathol. 2011; 48:117–131.
[17] Rasotto R, Berlato D, Goldschmidt MH, Zappulli V. Prognostic
Signicance of Canine Mammary Tumor Histologic Subtypes:
An Observational Cohort Study of 229 Cases. Vet. Pathol. 2017;
54:571–578.
[18] Elston C, Ellis I. Assessment of histological grade. Eds. Systemic
Pathology. The breast. London: Churchill Livingstone. 1998;
p365–84.
[19] Cassali GD, Jark PC, Gamba C, Damasceno KA, Estrela–Lima A,
Nardi AB de, Ferreira E, Horta RS, Bruna F, Sueiro FAR, Rodrigues
LCS, Nakagaki KYR. Consensus Regarding the Diagnosis, Prognosis
and Treatment of Canine and Feline Mammary Tumors – 2019. Braz.
J. Vet. Pathol. 2020; 13(3): 555 – 574. doi: https://doi.org/kghx
[20] Karayannopoulou M, Kaldrymidou E, Constantinidis TC, Dessiris
A. Histological grading and prognosis in dogs with mammary
carcinomas: Application of a human grading method. J..Comp.
Pathol. 2005; 133:246–252.
[21] Cohen J. Weighted kappa: Nominal scale agreement with
provision for scaled disagreement or partial credit. Psychol.
Bull. 1968; 70(4):213–20.
[22] Queiroga F, Raposo T, Carballo M, Prada J, Pires I. Canine
mammary tumours a model to study human breast cancer:
Most recent ndings. In vivo. 2011; 25(3):455–465.
[23] Burrai G. Gabrieli A, Moccia V, Zappulli V, Porcellato I, Brachelente
C, Pirino S, Polinas M, Antuofermo EA. Statistical Analysis of Risk
Factors and Biological Behavior in Canine Mammary Tumors: A
Multicenter Study.Anim. 2020; 10(9):1687. doi: https://doi.org/kghz
[24] Kurzman I, Gilbertson S. Prognostic factors in canine mammary
tumors. Semin. Vet. Med. Surg. (Small Animal). 1986; 1:25–32.
[25] Egenvall A, Bonnett B, Ohagen P, Olson P, Hedhammar A, von
Euler H. Incidence of and survival after mammary tumors in a
population of over 80,000 insured female dogs in Sweden from
1995 to 2002. Preven. Vet. Med. 2005; 69:109–127.
[26] Zatloukal J, Lorenzová J, Tichy F, Neâas A, Kecová H, Kohout P.
Breed and Age as Risk Factors for Canine Mammary Tumours.
Acta Vet. Brno. 2005; 74:103–109.
[27] Benavente M, Bianchi C, Aba M. Canine mammary tumors: risk
factors, prognosis and treatments. J. Vet. Adv. 2016; 6(8):1291–1300.